Literature DB >> 18247553

Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

F Scott Kimball1, F Anthony Romero, Cyrine Ezzili, Joie Garfunkle, Thomas J Rayl, Dustin G Hochstatter, Inkyu Hwang, Dale L Boger.   

Abstract

A series of alpha-ketooxazoles containing conformational constraints in the flexible C2 acyl side chain of 2 (OL-135) and representative oxazole C5 substituents were prepared and examined as inhibitors of fatty acid amide hydrolase (FAAH). Exceptionally potent and selective FAAH inhibitors emerged from the series (e.g., 6, Ki = 200 and 260 pM for rat and rhFAAH). With simple and small C5 oxazole substituents, each series bearing a biphenylethyl, phenoxyphenethyl, or (phenoxymethyl)phenethyl C2 side chain was found to follow a well-defined linear relationship between -log Ki and Hammett sigmap of a magnitude (rho = 2.7-3.0) that indicates that the substituent electronic effect dominates, confirming its fundamental importance to the series and further establishing its predictive value. Just as significantly, the nature of the C5 oxazole substituent substantially impacts the selectivity of the inhibitors whereas the effect of the C2 acyl chain was more subtle but still significant even in the small series examined. Combination of these independent features, which display generalized trends across a range of inhibitor series, simultaneously improves FAAH potency and selectivity and can provide exquisitely selective and potent FAAH inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247553      PMCID: PMC2734917          DOI: 10.1021/jm701210y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  66 in total

1.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

2.  Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.

Authors:  D G Deutsch; R Omeir; G Arreaza; D Salehani; G D Prestwich; Z Huang; A Howlett
Journal:  Biochem Pharmacol       Date:  1997-02-07       Impact factor: 5.858

3.  Molecular characterization of human and mouse fatty acid amide hydrolases.

Authors:  D K Giang; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.

Authors:  D G Deutsch; S Lin; W A Hill; K L Morse; D Salehani; G Arreaza; R L Omeir; A Makriyannis
Journal:  Biochem Biophys Res Commun       Date:  1997-02-03       Impact factor: 3.575

5.  Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.

Authors:  L De Petrocellis; D Melck; N Ueda; S Maurelli; Y Kurahashi; S Yamamoto; G Marino; V Di Marzo
Journal:  Biochem Biophys Res Commun       Date:  1997-02-03       Impact factor: 3.575

6.  Inhibitors of arachidonoyl ethanolamide hydrolysis.

Authors:  B Koutek; G D Prestwich; A C Howlett; S A Chin; D Salehani; N Akhavan; D G Deutsch
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

7.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

8.  Attenuation of allergic contact dermatitis through the endocannabinoid system.

Authors:  Meliha Karsak; Evelyn Gaffal; Rahul Date; Lihua Wang-Eckhardt; Jennifer Rehnelt; Stefania Petrosino; Katarzyna Starowicz; Regina Steuder; Eberhard Schlicker; Benjamin Cravatt; Raphael Mechoulam; Reinhard Buettner; Sabine Werner; Vincenzo Di Marzo; Thomas Tüting; Andreas Zimmer
Journal:  Science       Date:  2007-06-08       Impact factor: 47.728

9.  Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Authors:  Christophe Hardouin; Michael J Kelso; F Anthony Romero; Thomas J Rayl; Donmienne Leung; Inkyu Hwang; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2007-06-09       Impact factor: 7.446

10.  Chemical characterization of a family of brain lipids that induce sleep.

Authors:  B F Cravatt; O Prospero-Garcia; G Siuzdak; N B Gilula; S J Henriksen; D L Boger; R A Lerner
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

View more
  21 in total

1.  Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.

Authors:  Jessica K DeMartino; Joie Garfunkle; Dustin G Hochstatter; Benjamin F Cravatt; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

Review 2.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

Review 3.  The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Katerina Otrubova; Cyrine Ezzili; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

4.  Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders.

Authors:  Kay Ahn; Douglas S Johnson; Benjamin F Cravatt
Journal:  Expert Opin Drug Discov       Date:  2009-07       Impact factor: 6.098

5.  Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

6.  Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

Authors:  Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; Dale L Boger
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

7.  α-Ketoheterocycle-based Inhibitors of Fatty Acid Amide Hydrolase (FAAH).

Authors:  Katerina Otrubova; Dale L Boger
Journal:  ACS Chem Neurosci       Date:  2011-12-20       Impact factor: 4.418

8.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

9.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  Discovery libraries targeting the major enzyme classes: the serine hydrolases.

Authors:  Katerina Otrubova; Venkat Srinivasan; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.